Cell and animal models of SARS-CoV-2 pathogenesis and immunity
The spread of the novel virus SARS coronavirus 2 (SARS-CoV-2) was explosive, with cases first identified in December 2019, and >22 million people infected and >775,000 deaths as of August 2020. SARS-CoV-2 can cause severe respiratory disease in humans leading to coronavirus disease 2019 (COVID...
Saved in:
Main Authors: | Sarah R. Leist (Author), Alexandra Schäfer (Author), David R. Martinez (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on SARS-CoV-2: Pathogenesis, Immunity, Treatment Protocol and Vaccines in Perspective
by: K M Vidya
Published: (2020) -
SARS-CoV-2 and the nervous system: review on pathogenesis of nervous system SARS-CoV-2 damage
by: Bai, Francesca
Published: (2021) -
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
by: G. Kanimozhi, et al.
Published: (2021) -
Current understanding of T cell immunity against SARS-CoV-2
by: Xiuyuan Lu, et al.
Published: (2022) -
Human-Animal Interaction and the Emergence of SARS-CoV-2
by: Hassani, Asma, et al.
Published: (2020)